What Is Actemra?
Actemra (tocilizumab) is an injectable drug that is prescribed to treat chronic inflammation associated with rheumatoid arthritis or Giant Cell Arteritis (GCA). The FDA approved the drug in 2010. Actemra is made and marketed by Hoffman La Roche/Genentech.
What Are The Risks Associated With Actemra?
Reports produced by the FDA and published investigations related to Actemra reveal an alarming number of adverse reactions including:
- Heart Failure
- Heart Attack
- Lung Disease
- Gastrointestinal Perforation
- Death From Any Of The Conditions Listed Above
Actemra does not warn consumers about these risks, even though Actemra’s competitors at least warn of some of these risks.
What Does It Cost To Find Out If I Have A Case?
Nothing. Call us toll free at (877) 704-7674 for a free case evaluation. You’ll speak to a lawyer with more than 20 years of experience, not a case screener. We will take the time to discuss your case and your legal options. If your case proceeds to the investigation and litigation phase, we cover those costs. We are paid for our time and repaid for case expenses only if you make a financial recovery in the form of a settlement or verdict. We are accepting Actemra cases from all 50 states.
When Can I Expect A Settlement?
The Actemra litigation is just starting. There have been no Actemra trials or reports of settlements. Don’t let the early stage of this litigation cause you to delay. You have a legal deadline (called the statute of limitations) to file your case and failure to meet that deadline will cause you to lose your right to pursue your claim. Depending on the circumstances of your case, this deadline to file suit could be fast approaching. Call us toll free at (877) 704-7674 so that we can protect your right to pursue your case.
Learn More About Actemra